180 related articles for article (PubMed ID: 12079443)
21. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
Rodrigues LC; Pereira SM; Cunha SS; Genser B; Ichihara MY; de Brito SC; Hijjar MA; Dourado I; Cruz AA; Sant'Anna C; Bierrenbach AL; Barreto ML
Lancet; 2005 Oct; 366(9493):1290-5. PubMed ID: 16214599
[TBL] [Abstract][Full Text] [Related]
22. Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guérin (BCG) vaccines from different sources, Kazakhstan.
Favorov M; Ali M; Tursunbayeva A; Aitmagambetova I; Kilgore P; Ismailov S; Chorba T
PLoS One; 2012; 7(3):e32567. PubMed ID: 22427854
[TBL] [Abstract][Full Text] [Related]
23. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
[TBL] [Abstract][Full Text] [Related]
24. Clinical and economic impact of a specific BCG vaccination program implemented in Prato, central Italy, involving foreign newborns on hospitalizations.
Bellini I; Nastasi A; Boccalini S
Hum Vaccin Immunother; 2016 Sep; 12(9):2383-90. PubMed ID: 27184892
[TBL] [Abstract][Full Text] [Related]
25. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
26. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Sterne JAC; Abubakar I; Smith PG; Fine PEM; Vynnycky E; Watson JM; Elliman D; Lipman M; Rodrigues LC
Int J Epidemiol; 2018 Feb; 47(1):193-201. PubMed ID: 29025083
[TBL] [Abstract][Full Text] [Related]
27. [BCG revaccination of school children in circumstances of low incidence of tuberculosis].
Lebedeva LV; Aksenova VA; Ioramashvili NG; Puchkov KG; Levi DT; Gorovenko LI
Probl Tuberk; 1992; (1-2):15-8. PubMed ID: 1603781
[TBL] [Abstract][Full Text] [Related]
28. [BCG vaccines for the prevention of tuberculosis in the world].
Hashimoto T
Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
[TBL] [Abstract][Full Text] [Related]
29. Ten Years' Experience with the Discontinuation of the Bacillus Calmette-Guérin Vaccination in the Czech Republic.
Doležalová K; Göpfertová D
Int J Mycobacteriol; 2021; 10(2):193-198. PubMed ID: 34558474
[TBL] [Abstract][Full Text] [Related]
30. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.
Barreto ML; Pereira SM; Pilger D; Cruz AA; Cunha SS; Sant'Anna C; Ichihara MY; Genser B; Rodrigues LC
Vaccine; 2011 Jul; 29(31):4875-7. PubMed ID: 21616115
[TBL] [Abstract][Full Text] [Related]
31. A strong tuberculin reaction in primary school children predicts tuberculosis in adolescence.
Leung CC; Yew WW; Au KF; Tam CM; Chang KC; Mak KY; Tam SY; Chan KF; Fong KL; Tam SW
Pediatr Infect Dis J; 2012 Feb; 31(2):150-3. PubMed ID: 21983215
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.
Tseng CL; Oxlade O; Menzies D; Aspler A; Schwartzman K
BMC Public Health; 2011 Jan; 11():55. PubMed ID: 21269503
[TBL] [Abstract][Full Text] [Related]
33. [Tuberculosis control strategy in the 21st century in Japan--for elimination of tuberculosis in Japan].
Aoki M
Kekkaku; 2001 Jul; 76(7):549-57. PubMed ID: 11517563
[TBL] [Abstract][Full Text] [Related]
34. A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil.
Dantas OM; Ximenes RA; de Albuquerque Mde F; da Silva NL; Montarroyos UR; de Souza WV; Pereira TC; Campelo AR; Rodrigues LC
Int J Tuberc Lung Dis; 2006 May; 10(5):536-41. PubMed ID: 16704036
[TBL] [Abstract][Full Text] [Related]
35. Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis.
Ditkowsky JB; Schwartzman K
PLoS One; 2014; 9(1):e83526. PubMed ID: 24454706
[TBL] [Abstract][Full Text] [Related]
36. [Reform of Japan's NTP and its technical perspectives].
Mori T
Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
Faust L; Schreiber Y; Bocking N
BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
[TBL] [Abstract][Full Text] [Related]
38. [Results of the BCG vaccination in Hungary since 1929: evaluation of preventive and immunotherapeutic effectiveness].
Lugosi L
Orv Hetil; 1998 Jun; 139(26):1563-70. PubMed ID: 9676117
[TBL] [Abstract][Full Text] [Related]
39. A review of the literature on the economics of vaccination against TB.
Tu HA; Vu HD; Rozenbaum MH; Woerdenbag HJ; Postma MJ
Expert Rev Vaccines; 2012 Mar; 11(3):303-17. PubMed ID: 22380823
[TBL] [Abstract][Full Text] [Related]
40. Bacillus Calmette-Guérin (BCG) Revaccination and Protection Against Tuberculosis: A Systematic Review.
Lawrence A
Cureus; 2024 Mar; 16(3):e56643. PubMed ID: 38646352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
